How to Manage the Risk of Colorectal Cancer in Ulcerative Colitis

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|10|1424-1432

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.10, 2011-09, pp. : 1424-1432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How to Manage Pouchitis in Ulcerative Colitis?

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1454-1461

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical characteristics of ulcerative colitis‐related colorectal cancer in Chinese patients

By  

Journal of Digestive Diseases, Vol. 18, Iss. 12, 2017-12 ,pp. : 684-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Critical Review of the Evidence on 5-Aminosalicilate for Chemoprevention of Colorectal Cancer in Ulcerative Colitis: A Methodological Question

By  

Current Clinical Pharmacology, Vol. 9, Iss. 1, 2014-02 ,pp. : 84-90

Bentham Science Publishers

Access to resources Recommend Favorite

How Important is Onset of Action in Ulcerative Colitis Therapy?

By Masson Steven  

Drugs, Vol. 65, Iss. 15, 2005-01 ,pp. : 2069-2083

Adis International

Access to resources Recommend Favorite

Ulcerative Colitis: Pathogenesis

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1373-1382

Bentham Science Publishers

Access to resources Recommend Favorite